Back to Agenda
Improving Investigative Site Selection Practices
Session Chair(s)
Kenneth Getz, MBA
Tufts Center for the Study of Drug Development
Center For the Study of Drug Development, United States
Advancing a Data-Driven Foundation for Investigative Site and Country Selection Strategies
Learning Objective : Review data characterizing the changing global investigative site landscape; Assess site characteristics that are predictive of clinical trial performance; Discuss the attributes and anticipated value of Investigator Databank.
Speaker(s)
Anticipating Trends and Changes in the Fragmented Global Investigative Site Landscape
Kenneth Getz, MBA
Center For the Study of Drug Development, United States
Tufts Center for the Study of Drug Development
Advancing a Data-Driven Foundation for Investigative Site and Country Selection Strategies
Shawn Tedman, MBA
ixlayer, United States
VP, Biopharma Innovation
Investigator Databank Collaboration: A Global Platform for Precompetitive Sharing
Elisa Cascade, MBA
Advarra, United States
Chief Product Officer
Have an account?